Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA)
- First Posted Date
- 2023-01-25
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- Kainos Medicine Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT05695378
- Locations
- 🇰🇷
CHA Bundang Medical Center, CHA University, Seongnam-si, Gyeonggi-do, Korea, Republic of
Phase I, KM-819 in Healthy Subjects for Parkinson's Disease
- First Posted Date
- 2017-01-18
- Last Posted Date
- 2020-04-13
- Lead Sponsor
- Kainos Medicine Inc.
- Target Recruit Count
- 88
- Registration Number
- NCT03022799
- Locations
- 🇰🇷
CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggi-do, Korea, Republic of
Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023
Phase 1
Completed
- Conditions
- Human Immunodeficiency Virus
- Interventions
- Drug: Placebo for KM-023
- First Posted Date
- 2011-05-05
- Last Posted Date
- 2012-07-26
- Lead Sponsor
- Kainos Medicine Inc.
- Target Recruit Count
- 83
- Registration Number
- NCT01348516
- Locations
- 🇰🇷
Clinical Trials Center, Seoul National University Hospital, Seoul, Korea, Republic of
News
No news found